Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12371399 | 0.82 | — | — | |
| SCHEMBL15085722 | 0.79 | ALOX15 (0.30) | ALOX15TSHR | |
| SCHEMBL15085721 | 0.79 | ALOX15 (0.30) | ALOX15TSHR | |
| SCHEMBL12371358 | 0.74 | — | — | |
| SCHEMBL15095167 | 0.72 | — | — | |
| SCHEMBL31497745 | 0.69 | BCHE (0.40) | — | |
| SCHEMBL8223016 | 0.65 | CHRM2 (0.42) | TSHR | |
| SCHEMBL851415 | 0.65 | CA12 (0.35) | TSHR | |
| SCHEMBL15373008 | 0.65 | CA12 (0.35) | TSHR | |
| SCHEMBL11194228 | 0.60 | ALOX15 (0.36) | ALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8481728-B2 | Process for preparing entecavir and its intermediates | SCINOPHARM TAIWAN, LTD. (TW) | 2013-07-09 | — | — | US | disclosed |
| US-20110201809-A1 | Process for Preparing Entecavir and its Intermediates | SCINOPHARM TAIWAN, LTD. | 2011-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110201809-A1 | Process for Preparing Entecavir and its Intermediates | ENTPD5, TYMS, TYMP | ALOX15 1109/4885TSHR 3325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.